IP Library Granted Patent US 8,658,827
Granted Patent B2
US 8,658,827 · App. 13/313,902 · Granted Feb 25, 2014

Method for synthesizing substituted aminocyclohexanone compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,658,827
App. No.
13/313,902
Granted
Feb 25, 2014
Kind
B2
Abstract

A method of synthesizing a substituted aminocyclohexanone compound comprising reacting a compound of formula (II) with an organolithium compound to form a compound of formula (III)

Claims (36)

1. A method of synthesizing a compound of formula (IV)

wherein

R 1 denotes —H or —CH 3 , and

R 2 denotes —H, —Cl or —F;

said method comprising reacting a compound of formula (II)

with an organolithium compound of formula (VII)

wherein

R 2 denotes —H, —Cl or —F;

to form a compound of formula (III)

optionally methylating the amino function to obtain a compound in which R 1 is CH 3 , and

cleaving the ketal function of the compound of formula (III) to convert the compound of formula (III) into the compound of formula (IV).

2. The method according to claim 1 , wherein R 2 denotes —H.

3. The method according to claim 1 , comprising forming the compound of formula (II) by first reacting a compound of formula (I)

with methylamine.

4. The method according to claim 1 , further comprising converting the compound of formula (III) into a hydrochloride salt.

5. The method according to claim 1 , further comprising converting a hydrochloride salt of a compound of formula (III) into a free base.

6. The method according to claim 1 , wherein the ketal function of the compound of formula (III) is cleaved to obtain a compound of formula (IVa)

7. The method according to claim 6 , further comprising converting the compound of formula (IVa) into a hydrochloride salt.

8. The method according to claim 6 , further comprising converting a hydrochloride salt of a compound of formula (IVa) into a free base.

9. The method according to claim 1 , wherein the amino function of the compound of formula (III) is methylated to obtain a compound of formula (V)

10. The method according to claim 9 , wherein the methylation is effected by reacting the compound of formula (III) with formaldehyde solution and formic acid.

11. The method according to claim 9 , wherein the ketal function of the compound of formula (V) is cleaved to obtain a compound of formula (IVb)

12. A method of synthesizing a compound of formula (VI)

wherein

R 1 denotes —H or —CH 3 ,

or a physiologically acceptable salt thereof,

said method comprising

reacting a compound of formula (II)

with an organolithium compound of formula (VII)

wherein

R 2 denotes —H, —Cl or —F;

to form a compound of formula (III)

optionally methylating the amino function to obtain a compound in which R 1 is CH 3 ;

cleaving the ketal function of the compound of formula (III) to convert the compound of formula (III) into a compound of formula (IV)

and

subjecting the compound of formula (IV) to an acid-catalysed Oxa-Pictet-Spengler reaction with a heteroaromatic compound to form the compound of formula (VI).

Assignments (4)
CHANGE OF NAME Recorded May 21, 2025
From: PARK THERAPEUTICS, INC.
To: ADNEURIS THERAPEUTICS, INC.
Reel/Frame 071349/0825 →
SECURITY INTEREST Recorded Sep 26, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 069065/0576 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2021
From: GRÜNENTHAL GMBH
To: PARK THERAPEUTICS, INC.
Reel/Frame 057212/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2012
From: PRUEHS, STEFAN; GRIEBEL, CARSTEN; MUELLER, MARITA
To: GRUENENTHAL GMBH
Reel/Frame 027618/0001 →